Skip to main content
EarningsCallAI
ABBV

AbbVie Inc.

Healthcare

TAILWIND(HIGH)

Operator Signal: TAILWIND

Revenue growth is accelerating. This company is seeing consistent demand expansion, good signal for adjacent markets.

$16.6B
Latest Revenue
+10.0%
Revenue Growth (YoY)
$1.02
Latest EPS
$1.8B
Latest Net Income

Quarterly Earnings History

QuarterRevenueNet IncomeEPS
Q4 2025$16.6B$1.8B$1.02
Q3 2025$15.8B$186.0M$0.10
Q2 2025$15.4B$938.0M$0.52
Q1 2025$13.3B$1.3B$0.72
Q4 2024$15.1B$-22.0M$-0.02
Q3 2024$14.5B$1.6B$0.88
Q2 2024$14.5B$1.4B$0.77
Q1 2024$12.3B$1.4B$0.77

What This Means for Operators

AbbVie Inc. is in growth mode. Revenue is trending up quarter-over-quarter, which means the markets they serve are expanding. If you sell into the same ecosystem or serve similar customers, this is a green light.

When ABBV grows, they hire, they increase vendor budgets, and their customers have more budget too. Follow the money.

Data from SEC EDGAR. View original filings: AbbVie Inc. SEC Filings

Frequently Asked Questions

AbbVie Inc. (ABBV) currently has a TAILWIND operator signal with HIGH confidence. This signal is based on quarterly revenue trends and earnings patterns across 8 quarters of data.

AbbVie Inc.'s latest reported revenue is $16.6B, representing +10.0% year-over-year growth. Latest EPS was $1.02.

Based on 8 quarters of earnings data, AbbVie Inc. shows a TAILWIND signal. Revenue is trending upward, indicating growth.

AbbVie Inc.'s quarterly (10-Q) and annual (10-K) filings are available on SEC EDGAR. We analyze these filings to extract revenue, EPS, and net income data for our operator signal calculations.

Sources: SEC EDGAR
Last updated:

Operator signals are derived from quarterly revenue trends, EPS patterns, and net income direction across multiple quarters. Signals indicate momentum direction, not stock recommendations.